{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:08:39Z","timestamp":1778620119621,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.mayocp.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T06:04:10Z","timestamp":1361945050000},"page":"295-299","source":"Crossref","is-referenced-by-count":18,"title":["Current Issues in Contraception"],"prefix":"10.1016","volume":"88","author":[{"given":"Mary L.","family":"Marnach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret E.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra M.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2013.01.007_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.mayocp.2013.01.007_bib2","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2010: adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th ed","volume":"59","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2013.01.007_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/AOG.0b013e318227f05e","article-title":"ACOG Practice Bulletin No. 121: Long-acting reversible contraception: implants and intrauterine devices","volume":"118","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.mayocp.2013.01.007_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.mayocp.2013.01.007_bib5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/AOG.0b013e3182118ac3","article-title":"Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial","volume":"117","author":"Jensen","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mayocp.2013.01.007_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/AOG.0b013e3181cb50b5","article-title":"ACOG Practice Bulletin No. 110: Noncontraceptive uses of hormonal contraceptives","volume":"115","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.mayocp.2013.01.007_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.amjmed.2011.12.002","article-title":"Citalopram, QTc interval prolongation, and torsade de pointes: how should we\u00a0apply the recent FDA ruling?","volume":"125","author":"Vieweg","year":"2012","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2013.01.007_bib8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.mayocp.2012.07.009","article-title":"Considerations on safety concerns about citalopram prescribing","volume":"87","author":"Sheeler","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mayocp.2013.01.007_bib9","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2013.01.007_bib10","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2013.01.007_bib11","unstructured":"US Food and Drug Administration. Background Document for Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee. NDA 21-180 Ortho Evra. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/ReproductiveHealthDrugsAdvisoryCommittee\/UCM282634.pdf. Published December 9, 2011. Accessed December 28, 2012."},{"key":"10.1016\/j.mayocp.2013.01.007_bib12","unstructured":"US Food and Drug Administration. Birth control pills containing drospirenone: label change\u2014products may be associated with higher risk for blood clots. US Food and Drug Administration website. http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm299605.htm. Updated April 10, 2012. Accessed December 28,\u00a02012."},{"issue":"9190","key":"10.1016\/j.mayocp.2013.01.007_bib13","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestogens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.mayocp.2013.01.007_bib14","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2013.01.007_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11910-010-0174-7","article-title":"Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches","volume":"11","author":"Shuster","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"10.1016\/j.mayocp.2013.01.007_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11916-012-0278-7","article-title":"Hormonal contraception and migraine: clinical considerations","volume":"16","author":"Faubion","year":"2012","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2013.01.007_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2013.01.007_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.mayocp.2013.01.007_bib19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318273eb56","article-title":"Preventing unintended pregnancies by providing no-cost contraception","volume":"120","author":"Peipert","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2013.01.007_bib20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e3182723b7d","article-title":"Committee opinion no. 539: Adolescents and long-acting reversible contraception: implants and intrauterine devices","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.mayocp.2013.01.007_bib21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(11)70223-6","article-title":"Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies","volume":"12","author":"Castellsagu\u00e9","year":"2011","journal-title":"Lancet Oncol"},{"issue":"9599","key":"10.1016\/j.mayocp.2013.01.007_bib22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2013.01.007_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.mayocp.2013.01.007_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.contraception.2010.09.012","article-title":"Bleeding related to etonogestrel subdermal implant in a US population","volume":"83","author":"Casey","year":"2011","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.mayocp.2013.01.007_bib25","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/humrep\/dep081","article-title":"A\u00a0randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users","volume":"24","author":"Weisberg","year":"2009","journal-title":"Hum Reprod"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619613000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619613000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T11:31:06Z","timestamp":1539862266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619613000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0025619613000633"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2013.01.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}